Memory impairment in schizophrenia: perspectives from psychopathology and pharmacotherapy. (Record no. 8891816)

MARC details
000 -LEADER
fixed length control field 01390 a2200349 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250513103647.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 199703s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0706-7437
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1177/070674379604100822
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Stip, E
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 19970318
245 00 - TITLE STATEMENT
Title Memory impairment in schizophrenia: perspectives from psychopathology and pharmacotherapy.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Canadian journal of psychiatry. Revue canadienne de psychiatrie
Date of publication, distribution, etc. Oct 1996
300 ## - PHYSICAL DESCRIPTION
Extent S27-34 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Review
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Amnesia
General subdivision chemically induced
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antipsychotic Agents
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cholinergic Antagonists
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Clozapine
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Dibenzothiazepines
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Mental Recall
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Neuropsychological Tests
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Quetiapine Fumarate
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Retention, Psychology
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Risperidone
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Schizophrenia
General subdivision diagnosis
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Schizophrenic Psychology
773 0# - HOST ITEM ENTRY
Title Canadian journal of psychiatry. Revue canadienne de psychiatrie
Related parts vol. 41
-- no. 8 Suppl 2
-- p. S27-34
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1177/070674379604100822">https://doi.org/10.1177/070674379604100822</a>
Public note Available from publisher's website

No items available.